Seattle Genetics (SGEN) PT Raised to $200 at JMP Securities After Positive ESMO Data and Commentary
Tweet Send to a Friend
JMP Securities analyst Reni Benjamin raised the price target on Seattle Genetics (NASDAQ: SGEN) to $200.00 (from $185.00) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
